ACRS FY 2017 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

FY 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M

Gross Profit

$476,00028.3% margin

Operating Income

-$72M-4303.2% margin

Net Income

-$69M-4071.5% margin

EPS (Diluted)

$-2.44

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$56M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$244M

Total Liabilities

$18M

Stockholders' Equity

$225M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$476,000	-$120,000	+496.7%
Operating Income	-$72M	-$49M	-49.1%
Net Income	-$69M	-$48M	-42.5%